O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
about
Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and TreatmentMolecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug developmentSilencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagusAdvances in the management of paediatric high-grade glioma.A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors.O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction.Childhood brain tumors: epidemiology, current management and future directions.Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group.Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repairMolecular pathology in adult gliomas: diagnostic, prognostic, and predictive markersN-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomideO6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.A multi-institutional experience in pediatric high-grade glioma.Management of high-grade gliomas in the pediatric patient: Past, present, and future.DNA repair: from genome maintenance to biomarker and therapeutic target.Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factorsLong-term follow-up of children treated for high-grade gliomas: children's oncology group L991 final study report.Base excision repair: contribution to tumorigenesis and target in anticancer treatment paradigmsLong-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupInterplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysisTumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas.Diagnostic and therapeutic stratification of childhood brain tumors: implications for translational research.Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group.Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.Irradiation of pediatric high-grade spinal cord tumors.Double-labelling immunohistochemistry for MGMT and a "cocktail" of non-tumourous elements is a reliable, quick and easy technique for inferring methylation status in glioblastomas and other primary brain tumours.Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.Molecular diagnostics of gliomas: state of the art.Treatment of pituitary neoplasms with temozolomide: a review.Treatment of high-grade glioma in children and adolescents.Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.
P2860
Q26785952-524EDA94-C186-4F99-8364-750C30F6E6EFQ28475285-631EE1BD-9F9B-4F33-AB8D-1CC6E517B7D2Q30412980-1316C4A7-1DFA-4BF8-83C6-03CA3D9AA89AQ30870633-96647AF2-2D48-472D-B782-F69BD55E523EQ33379701-17496659-8CC5-4A4F-A75D-1659F537996FQ33416431-33A56CE1-4A11-488F-93CB-2C7E71358FCEQ33804528-1DE6C0E4-6543-41D2-ACB3-1B347F9F7437Q33970971-43939947-2B76-46AA-86EC-E2A57643BF36Q34221722-18C3335E-F9D0-40D5-A9C4-8C7E386AEED4Q34286305-5536D10C-743C-4826-A3E7-76A4AEE69855Q34565801-7FDCE068-50D2-48B5-A028-20B39B6F385FQ34722440-42B74F09-D081-4670-9A35-960CCE72AA22Q34802264-6CD9946B-ED22-4593-B469-ECDC28724123Q34815207-9075130F-0084-4F7D-AB50-5C74A7DA635DQ34977358-A3698FE4-E8C5-4B1E-9552-EA8A034271B6Q35001754-41DEDE9B-99FC-4906-B3D2-146B4A24F43FQ35070545-82B62A41-34AB-4967-8D21-BA6C49A7BE12Q35085329-5A6F6116-4F17-49A9-80DE-6F2C9329AF92Q35094432-6CECE248-24AF-4921-B647-1F77B7E85A0CQ35206259-717120BF-377E-43C0-A8C1-E0B0A9EF980CQ35555880-B2313DDC-B005-41A9-A522-055B2A3AF168Q35769714-08506AC0-D9F7-451A-AA14-9553B15C1258Q35925137-B247A038-8AB1-4531-BF1D-5C3619B0D3BFQ35955906-5500006A-A252-4C10-8FEC-1FAC680DBD5FQ35972863-3575E380-3A5E-4A71-88BE-CCFF88730A3DQ36010103-1210E0FC-EF45-47B0-A20E-67533C5801A4Q36268061-4D0B812E-B772-4513-A156-A85225542294Q36651893-0AE90C31-28EA-4879-933A-8873F1D50E16Q36908083-68AC1BCB-4026-4D11-92CE-DC419179DCA8Q37037132-1C704FAD-5973-49BD-BEA4-24934A033573Q37187676-13FAEC11-186F-4660-83CE-474F87C416EFQ37190159-F73650AE-0C3C-4E3A-AE03-63EFD44ACD97Q37394315-D866599F-F1DC-40F3-8753-C0F9C3C4819BQ37485637-13494E77-A367-40D5-ABE5-9E295CE973D4Q37564201-589F4E2B-9A44-4B76-B3F8-76B100EFBE8DQ37564835-B9F43A88-1F75-4284-8A3B-1086A1F88D3BQ37780495-B78420A1-B314-4A60-921B-8FD953204DEFQ37789267-5D1BD3B0-9DEB-4EBE-8F14-F4F3C618828CQ37904503-0EBF3691-54C2-407E-91B9-B12373EA00C8Q37955091-BFCBA4AF-46B5-45B4-BEA4-5C80436578A5
P2860
O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
O6-methylguanine-DNA methyltra ...... sults from the CCG-945 Cohort.
@en
type
label
O6-methylguanine-DNA methyltra ...... sults from the CCG-945 Cohort.
@en
prefLabel
O6-methylguanine-DNA methyltra ...... sults from the CCG-945 Cohort.
@en
P2093
P356
P1476
O6-methylguanine-DNA methyltra ...... sults from the CCG-945 Cohort.
@en
P2093
Allan J Yates
Emiko J Holmes
Ian F Pollack
Jonathan L Finlay
Judith Burnham
Robert W Sobol
Ronald L Hamilton
Tianni Zhou
P304
P356
10.1200/JCO.2006.05.7265
P407
P577
2006-07-01T00:00:00Z